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Abstract
The public commonly associates microorganisms with pathogens. This suspicion of microorganisms is understandable,
as historically microorganisms have killed more humans than any other agent while remaining largely unknown until
the late seventeenth century with the works of van Leeuwenhoek and Kircher. Despite our improved understanding
regarding microorganisms, the general public are apt to think of diseases rather than of the majority of harmless or
beneficial species that inhabit our bodies and the built and natural environment. As long as microbiome research was
confined to labs, the public’s exposure to microbiology was limited. The recent launch of global microbiome surveys,
such as the Earth Microbiome Project and MetaSUB (Metagenomics and Metadesign of Subways and Urban Biomes)
project, has raised ethical, financial, feasibility, and sustainability concerns as to the public’s level of understanding and
potential reaction to the findings, which, done improperly, risk negative implications for ongoing and future
investigations, but done correctly, can facilitate a new vision of “smart cities.” To facilitate improved future research, we
describe here the major concerns that our discussions with ethics committees, community leaders, and government
officials have raised, and we expound on how to address them. We further discuss ethical considerations of
microbiome surveys and provide practical recommendations for public engagement.
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Background
Until recently, microbial communities have typically
been studied in research facilities, largely out of the pub-
lic eye. The rapid advent of high-throughput molecular
techniques prompted a dramatic increase in the ability
to study these communities in the human body [1] and
over a wider range of habitats including urban [2, 3] and
indoor [4–7] environments. These studies have provided
valuable insight about the amount and type of bacteria
in our environment and their ecology, source [8], and
effects on our health [9] and behavior [10].
The vital contribution of microorganisms to our envir-
onment and health calls for large-scale efforts to chart
our indoor and immediate outdoor microbiome environ-
ments. Consequently, over the past decade [11] several
mapping efforts charting public restrooms [9], apart-
ments [10], university classrooms and office buildings
[11], hospitals [12], museum artifacts [13], dust [14],
metropolitan subways [2, 15–17] were launched. Reviews
regarding the scientific findings of these studies investi-
gating the “built environment” have recently been pub-
lished [18]. One notable initiative, the MetaSUB project,
originated to capture a city-scale molecular profile of
DNA collected in New York [2]. The project has now
grown into a consortium encompassing 72 major world-
wide cities. Such studies challenge our perception of
public health, safety, and privacy in urban environments,
and seek to advance new strategies to protect our
growing society, such as the design of “smart cities” that
convey early warnings for potential epidemics and genet-
ically protected infrastructure. While some studies aim
to involve public members and educate them about their
internal and external microbial environments, the
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growing number of community-level microbiome studies
could inadvertently bring a negative image of microor-
ganisms that would foster public fear [19] of such re-
search and impede future microbiome investigations.
Building on our years of experience in the Inter-
national MetaSUB Consortium [20–23], we compiled a
list of concerns—all raised during our discussions with
ethics committees, community leaders, and government
officials—and address them. We also discuss how
technological advances may change these assessments
and provide recommendations for public engagement in
future studies. The concerns identified and explained
here, and the recommendations for public engagement,
can be used as guidelines and benefit microbiome and
metagenome research.
The most common concerns associated with the
public impact of microbiome research
Ostracizing sensitive populations
Since the earliest human microbiome project in 1683
when Antonie van Leeuwenhoek scraped “gritty matter”
from between his teeth and visualized bacteria, research
on human-associated microorganisms has focused on
pathogens and the environments that allowed them to
flourish [24], linking the presence of microorganisms and
human contact with pathogenicity [25].
Microbiome studies are typically targeted, at least in
part, at quantifying microbial biodiversity. Biodiversity of
bacteria is measured in terms of taxonomy, diversity, evo-
lutionary distance, their amount or frequency, and dynam-
ics over time. Pathogenicity is related to, but not
necessarily linked with biodiversity. Nonetheless, the pres-
ence of microorganisms, cleanliness, sanitation, and health
quickly became embedded cross-culturally. These terms
and themes have been used as a pejorative that stigma-
tized individuals, people, cultures, places, and cities [26–
28]. “Dirt,” for instance, is a common pejorative in hy-
gienic racism that has been applied to minorities, disad-
vantaged communities, and indigenous people who were
then subjected to discrimination based on their hygiene
and health [29]. For instance, due to poor housing condi-
tions, Australian children living in remote indigenous
communities experience high rates of increased transmis-
sion of infection compared to other Australian children. Ra-
cism and housing conditions are both associated with child
health and with adult physical and mental health [29, 30].
That poverty, sanitation, and infection go hand in hand
have thereby contributed to the stigmatization of sensitive
populations. It follows that there is a well-placed concern
that investigating the microbiome of a location may lead to
its association with disease, to the detriment of its residents.
Recent studies, however, do not support the presumed
association between biodiversity and pathogenicity.
Microbiome studies can distinguish between ecologically
varied diverse regions, which can be influenced by
human biodiversity, and even reflected in the DNA left
on ATM keypads [31], showing that the bacterial diver-
sity is not generally related with pathogenicity or pov-
erty. For example, in New York City, the Bronx was the
most diverse borough both in terms of human and bac-
terial diversity [2]. Poverty rates in Manhattan are three
quarters those of Brooklyn [32], but they have similar
levels of bacterial diversity [2]. Governments are largely
responsible for sanitation systems, particularly in large
cities, and it is acknowledged that sanitary neglect is a
population-wide hazard. Moreover, microorganisms are
also produced by animals inhabiting the surrounding en-
vironment, like rats, dogs, and pigeons [2, 31]—and are
thought to be among the major sources of zoonotic in-
fections, such as T. gondii, in big cities [33]. The scien-
tific community should thereby be cognizant of the
language and its perception by the media and the gen-
eral public. Interestingly, advances in epidemiology over
the past two decades highlighted that “over-clean” envir-
onment pose a risk to human health, whereas exposure
to little dirt (and most importantly, microorganisms) can
be beneficial and even ward off disease [34, 35].
Drawing the public away from transit systems
Due to high levels of human traffic, handles, seats, and
even the air transport systems are often perceived to be
biologically contaminated [36–38]. Evidence suggests that
during an epidemic outbreak, individuals may alter their
behavior to reduce their risk of infection. For example,
during the 2009 H1N1 influenza, 16–25% of Americans
avoided places where many people gathered, including
public transportation [39]. Another example emerged dur-
ing the 2014 Ebola outbreak [40] when the Centers for
Disease Control and Prevention and World Health
Organization recommended screening airport passengers
arriving from countries with Ebola outbreaks [41, 42].
That outbreak caused significant financial damages, esti-
mated in billions of dollars [43]. Concerns regarding po-
tential public panic and financial and other damages to
the city that may be caused by sampling transportation
systems may, thereby, detract city officials from approving
microbiome surveys.
However, public officials should be made aware that
sampling the transport system can help monitor and
fight the spread of pathogenic microorganisms, particu-
larly during seasonal outbreaks, and develop strategies
that the public can adopt to improve travelers’ health,
alleviate their concerns [44], and promote the use of
public transport. Thus far, the majority of the bacteria
identified in transit systems were benign commensal
species typically found in our environment and skin
[16]. In a survey of New York subway systems,
Afshinnekoo et al. [2] found 1688 non-pathogenic
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bacteria species mostly associated with the skin flora.
Only 31% of the species were identified as potentially
opportunistic bacteria that, although possibly linked to
diseases in people with compromised immune defense,
are unlikely to be pathogenic in healthy individuals. The
viruses found in the NY subway system were also gener-
ally harmless, as most belonged to the bacteriophages
group that only infect bacteria [45]. We note, however,
that 48% of the DNA belonged to unidentified organ-
isms, which likely follow the proportion of other king-
doms of life that were identified: bacteria (46.9%),
eukaryotes (0.8%), viruses (0.03%), archaea (0.003%), and
plasmids (0.001%) [2]. Finding antibiotic resistance spe-
cies, not unexpectedly, is also unlikely. Only 8% of the
hand-touch surfaces in busses, trains, stations, hotels,
and public areas of a hospital in central London contained
methicillin-sensitive Staphylococcus aureus and no sites
grew methicillin-resistant S. aureus (MRSA) [46]. A
slightly higher percentage (28%) of bacteria cultured from
the surfaces of NYC subways showed resistance to stand-
ard antibiotics [2]. In both studies, antibiotic resistance
was defined by phenotypic assays. However, even when
pathogenic organisms are found, the majority of infections
can be avoided by washing hands with soap and water
[47]. Notably, Afshinnekoo et al.’s [2] survey of the NY
subway system was followed by a highest-ever peak in the
number of users of the transit system [48, 49].
Creating health risks to investigators
Generally, the risk for infection during sampling is con-
sidered low, and no greater than typical everyday life.
However, sampling specific sites, such as sewage sys-
tems, public toilets, or animals, may carry risk for inves-
tigators. For instance, sampling animals may put the
investigator at risk for zoonotic disease transmission,
and wastewater is known to contain viable human path-
ogens [50–52]. In addition to sampling animals and
wastewater, taking samples from hospitals may result in
exposure to antibiotic-resistant bacteria, such as MRSA
or Pseudomonas aeruginosa [53], yet the risk of actual
infection exists mostly for immunocompromised people
and not necessarily the scientists taking samples [54].
Nonetheless, to minimize the risk of exposure, investiga-
tors should adopt standard safety procedures such as
not being in close proximity to potentially contaminated
surfaces and animals. When sampling hospitals or public
transport systems, close contact with people should be
avoided. Hand washing can also significantly reduce the
risk of potential infections [47]. Wearing safety equip-
ment, such as face masks and gloves, protects workers
from potentially harmful microorganisms [55]. The
proper equipment should be selected based on the esti-
mated risk level of the studied site. For example, the
National Institute for Health and safety has a document
recommending different types of masks, based on the
potential hazard and professional judgment [56].
Disparaging cities and public sites
Similar to as discussed above, the public’s association be-
tween microbiology and disease may result in a negative
association for microbiome sampling sites. It is not un-
common to find reports of toxins and small particles
[57] alongside possible pathogenic microorganisms [58]
living in solid surfaces or the air, which arguably, causes
public anxiety. However, historical precedence can be
misleading in this case. In modern cities, gaining infor-
mation about microbial populations will enhance cities’
efforts to improve public health [59]. We thereby sug-
gest that microbiome studies will ultimately improve cit-
ies’ reputation via the public’s perception of greater
public health monitoring.
Research efforts targeted at the indoor environment
where most people spend ~ 90% of their time have sig-
nificant potential to improve public health. The linkages
between dust, microorganisms, and diseases such as
asthma and allergies are established but generally poorly
understood [60, 61]. It has been shown that dust
collected from air-conditioning filters had high level of
potentially harmful gram-negative bacteria [62]. Air-
conditioners and ventilation systems may also contain
bacteria, such as Mycobacterium tuberculosis, that can
contribute to the bad quality of the air in apartments
and buildings [62–64]. Hence, knowledge acquired about
the pathogens in our immediate surrounding can also
support efforts to improve the hygiene in public sites
and reduce the risk of disease spread [65]. Ongoing pub-
lic sampling and monitoring has an important role in al-
leviating existing fears of toxicity and pathogenicity.
Stigmatizing healthcare facilities as healthcare hazards
The problem of disease dissemination in healthcare facil-
ities has existed since their establishment. Hospitals are
the ideal environment for the spread of pathogenic bac-
teria, as both patients and health workers are in contact
with contaminated surfaces, immune-compromised pa-
tients, and each other. One in 25 US hospital patients
develops a nosocomial infection [66]; of those, one in 10
dies from their infection. Similarly, in Europe, 3.8% of
general ward and 15.3% intensive care unit patients ac-
quired at least one nosocomial infection during their
visit [67]. In some cases, patients are being advised to
limit their hospital visits not only because the depart-
ments are busy [68] but because patients are at risk of
contracting harmful infections [69–71]. These issues
have already shaped the image of healthcare facilities as
incubators that facilitate the creation and spread of
antibiotic-resistant “superbugs” [72], and they are more
acute in unhygienic institutions and those forced to
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release sick patients due to overcrowded departments,
chiefly during seasonal outbreaks [73, 74]. Even sinks for
hand washing have been recognized in aiding the spread of
antibiotic-resistant bacterial pathogens [75]. It is now widely
accepted that surfaces such as door handles, seats, and even
floors are contaminated and may facilitate the rapid acquisi-
tion of antimicrobial resistance (AMR) [76] and transmis-
sion of several pathogens such as MRSA, Vancomycin-
Resistant Enterococci (VRE), and norovirus [77–80].
While microbiome hospital surveys may reinforce this
image, they are a crucial step to find a solution to this
problem. For example, public microbiome projects like
the resistomap [81] have been valuable to understand
the spread of AMR. Hospital sampling also allows un-
derstanding how antibiotic resistance spread over time
and space, which allows healthcare practitioners to focus
efforts on preventing contamination [82]. Therefore, the
potential benefits in improving that treatment and the
well-being of patients [83] outweigh the potential con-
cerns regarding hospital swabbing. Such monitoring pro-
jects are currently underway [17, 84, 85].
In addition to informing control of AMR and primary
pathogens, microbiome surveys and monitoring efforts
may inform the control of opportunistic pathogens. For
example, Legionella grow in building plumbing systems
and have emerged as a significant liability and public
health concern for hospitals. Multiple strategies, such as
on-site disinfection, are employed to control these op-
portunistic pathogens [86]. As these pathogens grow
within a complex microbial ecology, microbiome moni-
toring has been proposed to inform their control [87].
Encouraging fears of water safety
The increasing international demand for bottled water
underscores a declining trust in water safety; indeed,
health concerns are listed as one of the chief drivers of
this demand [88]. Microbiological contamination has
long been a threat to water safety. This was first recog-
nized by Dr. John Snow after the cholera outbreak in
1854 in central London, which took the lives of more
than 500 people, and after which there was a new found
awareness that cholera and other pathogens could be
spread through the drinking water [89]. For these rea-
sons, water facilities in the UK and many other countries
are constantly monitored and tested for pathogens,
toxins, or other forms of contamination to limit poten-
tial public health impact [90].
Such monitoring, however, generally excludes sewage
conveyance and treatment systems that are known to
contain human and animal pathogens [50–52]. More-
over, not all public water sources around the globe are
being monitored regularly, or at all. Therefore, monitor-
ing pathogen presence and viability in water facilities is
essential to evaluate infectious risk and prioritize the
water sources that require increased monitoring [90].
This is essential to provide more comprehensive protec-
tion of the public’s safety and dynamic response to varie-
gated risk across a city’s sources of water. Efforts
informed by microbiome surveys are already underway
in various sites to improve pathogen detection methods
for water monitoring [91, 92].
Perpetuating privacy and confidentiality fears
As privacy is becoming a growing concern, there is an
increasing awareness of the risks of sharing information
online. Paradoxically, though hacking to obtain bio-
logical information is extremely rare compared to other
forms of hacking, the public is very conscious of privacy
invasion associated with biological data [93]. While indi-
vidual human identification from microbiome samples
has yet to be achieved, some of the privacy concerns are
valid. Fingertip microbial communities can show what
keys of a computer keyboard were used and how re-
cently, with traces being identifiable for up to 2 weeks at
room temperature [94]. Lax and colleagues [85] showed
that the microbiome of patients became more similar to
their room microbiome the longer they stayed there. In
other words, the room microbiome can be forensically
analyzed to trace its inhabitants, but not only them.
People have their own individual microbial “cloud” made
up of biological particles emitted at a rate of ~ 106 per
hour [95]. These airborne bacterial emissions contribute
to the settled particles around people and can potentially
be used to identify individuals or those who came in
contact with the person [96]. It is therefore conceivable
that sampling of crime scenes and suspects for their
microbiome will become a forensic utility in the future.
While privacy risks are realistic, the field of microbial
forensics today is still in its infancy, and the dynamic mi-
crobial nature poses great challenges that may question
the usefulness of microbial-based tool for forensics.
Franzosa et al. showed that individuals who supplied
their microbiome from skin and stool samples as well as
their genetic code could be identified with an 80% accur-
acy based on their stool sample; however, the accuracy
dropped to 30% when microbiome from other sites of
the body was sampled, such as skin and mouth [97].
This study and others indicate that it is potentially pos-
sible to match an individual with their microbiome;
however, the microbiome data are likely to be used in
conjunction with other data such as DNA profiles be-
cause microbiome composition could be influenced by
several factors such as cosmetics, antibiotic use, and
general state of health [98].
Another chief concern is that researchers will be able
to infer information about the individual’s health, habits,
and lifestyle from their microbiome profile, which may
then be accessed by third parties. This concern may also
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become realistic in the future when the microbiome can
be harnessed to accurately trace the recent historical
whereabouts of people [99]. Remarkably, microbiome
privacy advocates have already released devices that can
remove (enzymes) or replace (oligos) the DNA cloud
that we leave behind [100].
To address all these concerns, privacy and safety mea-
sures should be applied to the collection and storage of
microbiome data [101], and laws like the Genetic Infor-
mation Nondiscrimination Act (GINA) of 2008 should
be updated to include microbiome data. Such laws were
created to protect personal information gathered from
research involving collection of human data; however, in
the case of GINA, non-human information is not pro-
tected. Since microbial DNA data are commonly stored in
publicly available databases, there is a risk of identification
even when the data are “anonymized” [102]. Misconcep-
tions concerning anonymization and using meta-data re-
semble those made in the early genomic era, as human
genomic data and their annotation were readily available
online [103]. Previously, such a shift in data accessibility
(dbGAP) has been put in place by the NIH and only after
it became possible to extract information about individ-
uals based on their genetic data [104]. Proper security
measures should thereby be applied to microbiome data
to prevent them from becoming a privacy risk.
Raising new ethical questions
The huge leap in microbiome research enabled by rapid
sequencing technologies has resulted in the development
of large databases where microbial samples from humans
and the environment are stored. These collections raise
many questions [105] concerning the ethical and social
implications of sampling the human microbiome. The two
most contested subjects are returning the results to partic-
ipants and informed consent.
To address the first subject, we first have to formulate
the ethics that govern the microbiome by deciding
whether microorganisms are parts of our body or separ-
ate entities. Although they are clearly inter-connected
and exist as dynamic, continually exchanging ecosys-
tems, legally, they are often treated differently. If the
microbiome is separate from tissues, humans may have
fewer rights to their own microbiome than to their tis-
sues that harbor it. There are several reasons why the
decision is difficult. First, due to the infancy of human
microbiome studies, much of the data remain uncharted,
hard to interpret, and/or unmappable to known ge-
nomes. Second, encountering or searching for patho-
genic agents raises questions as to whether the findings
should be reported to patients or public health author-
ities [106], since the relationship between bacterial
colonization and infection is not yet clear. Moreover, there
is little clinical validation of microbiome results linking to
health or disease [107]. It can therefore be argued that it is
unethical to report any scientific findings back to partici-
pants, absent a clear indication and validation.
The second debatable subject deals with what in-
formed consent should encompass, particularly in the
absence of regulation on microbiome data. Currently,
many countries including the UK and USA have laws
that protect human subjects by requiring a full disclos-
ure of any potential risk and benefits in participation
[108]. In the UK, such laws fall under the remit of the
NHS ethics review procedure (i.e., mainly research in-
volving patients). However, as our understanding of the
human microbiome grows, the laws involving data pro-
tection should be revised and the requirements from re-
searchers should be clarified. For instance, the use of
extensive 15-pages consent forms written in extensive
verbiage, such as those used by the human microbiome
project (HMP), has been criticized [109]. It has been
proposed that a shorter version of the official consent
documents should be produced to maximize the amount
of crucial information the subject is expected to compre-
hend [110, 111].
Demonizing microorganisms
The idea that all bacteria are harmful and should be ex-
terminated is substantially incorrect “common know-
ledge,” yet various products are promoted in the popular
media that “kill 99.9% of all bacteria” [112]. Although we
are surrounded by information sources urging us to get
rid of bacteria as a source of morbidity and mortality,
most bacteria are harmless and, often, beneficial [113].
Of the many bacteria that colonize our skin, nasal pas-
sages, and colon generally positively contribute to our
well-being. The bacteria in our environment also influ-
ence our health and well-being [114–117]. Diverse col-
onies of bacteria live in symbiosis with our body and are
essential for the healthy functioning of multiple bodily
systems, like the GI tract. Disruption in the gut micro-
flora may cause irritable bowel disease (IBD), character-
ized by a continuous inflammatory process in the gut,
even after the primary pathogen has been eradicated
[118]. Further investigations into how to stabilize and
perhaps diversify our microenvironment may improve
our quality of life [119].
Bacteria are also notoriously associated with dirt, dis-
eases, and a general state of uncleanliness and struggling
with the poor public relations of bacteria can be ex-
pected to hinder public microbiome initiatives at various
levels. Nonetheless, similar to the complex interactions
of commensal, opportunistic, and pathogenic bacteria of
our internal microbiome, the bacteria of our external en-
vironment also have symbiotic relationships with each
other and us [4]. Indoor microbial communities have
been shown to significantly differ from the multiplicity
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of the outdoor microbiome described thus far [120]. The
indoor communities are affected by the selective pres-
sures of the environment, such as location, ventilation,
and the presence of other humans. Students in a class-
room increase the bacterial load of the air (by two orders
of magnitude) when compared to an empty classroom
[121]. Several studies have implied that a certain diver-
sity and amount of bacteria in our indoor environment
is beneficial and may prevent the development of
illnesses like asthma in early stages of life [114–116].
These studies, though limited in size, offer a new angle
to consider chronic illnesses and encourage a public’s re-
consideration of the value of bacteria and invite further
research in this field.
Recommendations
Based on our long-term experience with public engage-
ment [22, 122], we make several recommendations that
can enhance the accessibility and transparency of micro-
biome research. Establishing a website that outlines the
hypotheses, goals, and findings of the study would make
a useful resource of information. Business cards with the
website address, the purpose of the work, and its impli-
cations handed out to curious bystanders would mitigate
anxiety and allow quick dissemination of the research
data. Investigators should consider carefully how their
activities and results can be misinterpreted [123] and
avoid grades and labels. Keeping a live blog of the web-
site designed for the broader audience would allow the
team to announce upcoming steps and also share the ex-
perience of interacting with the public [124]. Such a
platform will allow the researchers to promote the study
on social media (Facebook and YouTube) as well as on
various forums and encourage dialog between re-
searchers, participants, and the general public [125].
We note that several guidelines for public engagement
are already in place. For instance, the Responsible
Research and Innovation (RRI) is an initiative by the
European Union working toward an open science and
innovation system that ultimately tackles societal
changes [126]. It promotes the active engagement of key
stakeholder groups (for example, members of the public,
representatives of relevant interest groups, and leaders
of relevant organizations), from the earliest stages of a
project in order to ensure that the research is designed
in close consultation with them and takes into account
their questions and concerns. This could be a useful
approach for researchers wishing to undertake micro-
biome studies to adopt existing guidelines set by these
organizations.
Therefore, meeting with decision makers in the rele-
vant organizations to secure their support of the project
is a recommended step to keep the public representa-
tives informed of ongoing research, as is now done with
the City Council in NYC. This may also yield fruitful
collaborations, as science can be linked with politics to
increase the public outreach [127]. An example of public
engagement could be delivering short tutorials for
school children on the importance of washing hands and
improving the overall hygiene in schools. Also, such
engagement enables the teaching of emerging aspects of
microbiome and metagenomics research, including epi-
genetics [128], extremophiles [129], and even studies of
microbiomes in space [130]. Finally, it is important to
communicate and evaluate the risks of identification
from microbial samples and the accidental human DNA
collected in the process to the public.
Conclusions
Genome-enabled technologies created a dramatic in-
crease in our ability to study the microbiome in various
environments and hosts including our, largely uncharted,
indoor and outdoor environments. The insights gained
from this research may substantially alter our prior per-
ceptions on microorganisms and their effect on our lives
and health. While the public has shown an interest in
projects aiming to chart the gut microbiome of humans
[131] or animals [132] and even test the microbiome be-
havior in space [7], there remain concerns that micro-
biome mapping of the open space environment would
raise major public concerns, reservations from using
public facilities, and social unrest. To make such re-
search possible, it is imperative that scientists would
understand these risks, develop research projects that
mitigate them, and report the results in a responsible,
transparent, and accurate manner.
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